RT Journal Article
SR Electronic
T1 Pregnant women’s attitudes and behaviours towards antenatal vaccination against Influenza and COVID-19 in the Liverpool City Region, United Kingdom: cross-sectional survey
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.13.22279846
DO 10.1101/2022.09.13.22279846
A1 Kilada, Samantha
A1 French, Neil
A1 Perkins, Elizabeth
A1 Hungerford, Dan
YR 2022
UL http://medrxiv.org/content/early/2022/09/14/2022.09.13.22279846.abstract
AB Objective Influenza poses a serious health risk to pregnant women and their babies. Despite this risk, influenza vaccine uptake in pregnant women in the UK is less than 50%. Little is known about how COVID-19 affects pregnant women, but its management may affect attitudes and behaviours towards vaccination in pregnancy. The study objectives were to establish attitudes and knowledge of pregnant women towards influenza disease and influenza vaccination and to compare these to attitudes and knowledge about COVID-19 and COVID-19 vaccination.Design A cross-sectional survey was conducted using an online questionnaire distributed through local advertisement and social media outlets. Information was sought on attitudes and knowledge of influenza and COVID-19 and their respective vaccines.Participants and setting Pregnant women residing in Liverpool City Region, UKResults Of the 237 respondents, 73.8% reported receiving an influenza vaccine. Over half (56.5%) perceived themselves to be at risk from influenza, 70.5% believed that if they got influenza, their baby would get ill, and 64.6% believed getting influenza could hurt their baby, 60.3% believed that the influenza vaccine would prevent their baby from getting ill, and 70.8% believed it would protect their baby. Only 32.9% of respondents stated they would receive the COVID-19 vaccine if it were available to them. However, 80.2% stated they would receive a COVID-19 vaccine if they were not pregnant. Most of the women stated that they would accept a vaccine if recommended to them by healthcare professionals.Conclusions Acceptance of the influenza and COVID-19 vaccines during pregnancy seems to be more related to the safety of the baby rather than the mother. Women perceived their child to be more at risk than themselves. Information about influenza and COVID-19 vaccine safety as well as healthcare provider recommendations play an important role in vaccine uptake in pregnant women.Strengths and limitations of this studyThe study provides information on how a pandemic affects vaccine attitudes and behaviours during pregnancy.The study compares and contrasts attitudes and behaviours towards influenza and COVID-19 vaccines.The study provides new information relating to barriers to COVID-19 vaccine acceptance and provides insights into mechanisms for improving uptake.The sample size is small and self-selected which might lead to an over-representation of women likely to accept or have strong opinions on vaccinations.Responses to the questions on vaccine status are self-reported, not provided from healthcare records.Competing Interest StatementDH reports grants on the topic of rotavirus vaccines, outside of the submitted work, from GlaxoSmithKline Biologicals, Sanofi Pasteur and Merck and Co (Kenilworth, New Jersey, US) after the closure of Sanofi Pasteur-MSD in December 2016. NF reports grants on the topic of rotavirus vaccines, outside of the submitted work, from GlaxoSmithKline Biologicals. Samantha Kilada and Elizabeth Perkins have nothing to disclose.Funding StatementNo study-specific funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The project received ethical approval from the University of Liverpool Health and Life Sciences Research Ethics Committee (Human participants, tissues and databases) (approval number: 7865). The online survey was anonymous and valid informed consent was gained from study participants prior to completion of the questionnaire; recoded using clear affirmative action by use of a consent checkbox. The ethics committee approved this method of valid informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data in this study was collected via a survey from members of the public. As the study participants did not explicitly consent to their data being made available in a public repository, we have been advised by the University of Liverpool Research Data Management Team (rdm{at}liverpool.ac.uk) that it is not appropriate to make the data available in this format. However, datasets used and/or analysed during the current study may be available from the corresponding author on reasonable request.